Class summary at a glance.

Every drug in the Lincosamide Antibacterial class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 4tracked in Part D
CY24 Part D spend: $730703combined across class
Total Rx claims: 7K6K unique beneficiaries
Generic mfrs (active): 7across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Clindamycin Palmitate

Brand: Cleocin Pediatric · 7K Part D claims (CY24) · 6K beneficiaries · First FDA approval: 1986-04-17

7 generic mfrs Discontinued

Low NADAC$0.139

→

Avg plan cost$0.139

Part D spend $730703 1× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Clindamycin In 5 Percent Dextrose

— Part D claims (CY24) · First FDA approval: 2013-02-07

Brand-only (no generics) 84 plans require PA Active FDA shortage

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Clindamycin In Percent Dextrose

Brand: Clindamycin in 5 percent Dextrose · — Part D claims (CY24) · First FDA approval: 2024-06-12

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Clindamycin and Benzoyl Peroxide

Brand: Acanya · — Part D claims (CY24) · First FDA approval: 2009-08-25

Brand-only (no generics) 0 plans require PA Discontinued

Low NADAC$0.432

→

Avg plan cost$1.04

Part D spend — 2× spread, current vs floor

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.